skip to main content

Colitis-associated colorectal cancer surveillance — ESEGH MCQ

Instant feedback + full explanation. One question, done properly.

HardGI CancerColitis-associated colorectal cancer surveillanceESEGH

A 42-year-old man has had extensive ulcerative colitis for 10 years. He is in clinical remission on mesalazine. His father developed colorectal cancer aged 49. The last colonoscopy 3 years ago showed mild chronic inflammation but no dysplasia. What is the most appropriate management?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: B — Risk-stratified surveillance colonoscopy now

The best answer is “Risk-stratified surveillance colonoscopy now”. Risk-stratified surveillance colonoscopy now The alternatives “Continue the previous three-year interval”, “Defer surveillance until symptoms develop”, “Arrange colectomy without repeat endoscopy”, “Use faecal immunochemical testing instead of surveillance” are plausible in related gastroenterology presentations but do not match the defining finding, threshold, sequence or UK pathway in this stem.

Reference: BSG inflammatory bowel disease guideline: https://gut.bmj.com/content/68/Suppl_3/s1